Pain after Whiplash:A Prospective Controlled Inception Cohort Study
JNNP 66:279-283, Obelieniene,D.,et al, 1999
A Critical Appraisal of the Chronic Whiplash Syndrome
JNNP 66:273-276, Pearce,J.M.S., 1999
Diagnostic Criteria for Parkinson Disease
Arch Neurol 56:33-39, Gelb,D.J.,et al, 1999
The Heidenhain Variant of Creutzfeldt-Jakob Disease
Arch Neurol 56:55-61, Kropp,S.,et al, 1999
Adult-Onset MELAS Presenting as Herpes Encephalitis
Arch Neurol 56:241-243, Sharfstein,S.R.,et al, 1999
Screening for Dementia with the Memory Impairment Screen
Neurol 52:231-238,224, Buschke,H.,et al, 1999
Progressive Aphasia with Rapidly Progressive Dementia in a 49 Year Old Woman
JNNP 66:238-243, Greene,J.D.W.,et al,, 1999
Fatal Guillain-Barre Syndrome
Neurol 52:635-638, Lawn,N.D.&Wijdicks,E.F.M., 1999
Neuropsychological Status in Multiple Sclerosis after Treatment with Glatiramer
Arch Neurol 56:319-324, Weinstein,A.,et al, 1999
Spatz-Lindenberg Disease,A Rare Cause of Vascular Dementia
Stroke 30:687-689, Larner,A.J.,et al, 1999
Current and Remote Blood Pressure and Cognitive Decline
JAMA 281:438-445, Glynn,R.J.,et al, 1999
"Telestroke",The Application of Telemedicine for Stroke
Stroke 30:464-469, Levine,S.R.&Gorman,M., 1999
Hashimoto's Encephalitis as a Differential Diagnosis of Creutzfeldt-Jakob Disease
JNNP 66:172-176, Seipelt,M.,et al, 1999
Dementia and Snoring
Lancet 353:204, Steiner,M.C.,et al, 1999
Treatment of Intracranial Aneurysms by Embolization with Coils,A Systematic Review
Stroke 30:470-476, Brilstra,E.H.,et al, 1999
Risk Factors for Seizure-Related Motor Vehicle Crashes in Patients with Epilepsy
Neurol 52:1324-1329,1306, Krauss,G.L.,et al, 1999
Physician Assistants in Neurology Practice
Neurol 52:1513, Taft,J.M.&Hooker,R.S., 1999
Advances in Cancer Pain
Arch Neurol 56:413-417, Foley,K.M., 1999
Mortality from Dementia in Occupations at Risk of Exposure to Bovine Spongiform EncephalopathyAnalysis of Death Registrations
BMJ 318:1044-1045, Aylin,P.,et al, 1999
Outcome in Severe Pediatric Guillain-Barre Syndrome after Immunotherapy or Supportive Care
Neurol 52:1494-1497, Graf,W.D.,et al, 1999
Atypical Form of Amyotrophic Lateral Sclerosis
JNNP 66:581-585, Sasaki,S.&Iwata,M., 1999
Practice Parameter:The Care of the Patient with Amyotrophic Lateral Sclerosis (An Evidence-Based Review), Report of the Quality Standards Subcommittee of the AAN
Neurol 52:1311-1323, Miller,R.G.,et al, 1999
Clumsiness, Confusion, Coma, and Valproate
Lancet 353:1408, Ellaway,C.J.,et al, 1999
Current Therapy for Brain Tumors, Back to the Future
Arch Neurol 56:429-432, Shapiro,W.R., 1999
Prevalence and Clinical Correlates of Psychotic Symptoms in parkinson Disease
Arch Neurol 56:595-601, Aarsland,D.,et al, 1999
A Sneezer's Headache
Neurol 53:654-655, Kurita,H.,et al, 1999
Intravenous Immunoglobulin Treatment in Neurologic Disorders
Arch Neurol 56:1025-1027,1032, Sorensen,P.S., 1999
Is the Routine Use of Intravenous Immunoglobulin Treatment in Neurologic Disorders Justified?
Arch Neurol 56:1028-1032, Karussis,D.&Abramsky,O., 1999
Tracheostomy, In Guillain- Barre Syndrome
Muscle & Nerve 22:1058-1062, Lawn,N.D.&Wijdicks,E.F.M., 1999
Recent Advances, Neurology
BMJ 319:362-366, Larner,A.J.&Farmer,S.F., 1999
Prognostic Factors of Guillain-Barre Syndrome After Intravenous Immunoglobulin or Plasma Exchange?
Neurol 53:598-604, Visser,L.H.,et al, 1999
Adult-Onset Nemaline Myopathy:Another Cause of Dropped Head
Muscle & Nerve 22:1146-1150, Lomen-Hoerth,C.,et al, 1999
Maternal Thyroid Deficiency During Pregnancy and Subsequent Neuropsychological Development of the Child
NEJM 341:549-555,601, Haddow,J.E.,et al, 1999
Do We Have Drugs for Dementia? No
Arch Neurol 56:735-737, Pryse-Phillips,W., 1999
Do We Have a Treatment for Alzheimer Disease? Yes
Arch Neurol 56:738-739,735, Gauthier,S., 1999
Falling Asleep at the Wheel:Motor Vehicle Mishaps in Persons Taking Pramipexole and Ropinirole
Neurol 52:1908-1910, Frucht,S.,et al, 1999
Low-Density Lipoprotein Cholesterol and the Risk of Dementia with Stroke
JAMA 282:254-260, Moroney,J.T.,et al, 1999
Variability in Annual Mini-Mental State Examination Score in Patients with Probable Alzheimer Disease
Arch Neurol 56:857-862, Clark,C.M.,et al, 1999
Chronic Cryptogenic Sensory Polyneuropathy,Clinical and Laboratory Characteristics
Arch Neurol 56:540-547, 519, Wolfe,G.I.,et al, 1999
MR Imaging of Dejerine-Sottas Disease
AJNR 20:378-380, Make,D.D.,et al, 1999
Infantile Neuroaxonal Dystrophy,Clinical Spectrum and Diagnostic Criteria
Neurol 52:1472-1478, Nardocci,N.,et al, 1999
Sjogren-Larsson Syndrome, Clinical and MRI/MRS Findings in FALDH-Deficient Patients
Neurol 52:1345-1352,1307, Van Domburg,P.H.M.F.,et al, 1999
Dementia as the Most Common Presentation of Cortical-Basal Ganglionic Degeneration
Neurol 53:1969-1974, Grimes,D.A.,et al, 1999
Immunologic Treatment of Alzheimer's Disease
NEJM 341:1694-1695, Blass,J.P., 1999
Clinicopath Conf,Guillain-Barre Syndrome, Campylobacter Jejuni Enteritis,Case 39-1999
NEJM 341:1996-2003, , 1999
Folic Acid for the Prevention of Neural Tube Defects
Pediartrics 104:325-327, Committee on Genetics, 1999
Highly Active Antiretroviral Therapy Reverses Brain Metabolite Abnormalities in Mild HIV Dementia
Neurol 53:782-789, Chang,L.,et al, 1999
Neurologic Complications Associated with Hepatitis C Virus Infection
Neurol 53:861-864, Tembl,J.I.,et al, 1999
Isolated Trochlear Nerve Palsy in Patients with Multiple Sclerosis
Neurol 53:877-879, Jacobson,D.M.,et al, 1999
Altered Brain Activation in Cognitively Intact Individuals at High Risk for Alzheimer's Disease
Neurol 53:1391-1396, Smith,C.D.,et al, 1999